Savannah J. Dowling
Lawyers
Filters
RAPT Therapeutics $150 million at-the-market offering
The shares are listed on the Nasdaq Global Market
NGM Biopharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Ionis Pharmaceuticals $575 million convertible senior notes offering
The 1.75% convertible senior notes are due 2028
Weyerhaeuser $750 million notes offering
The investment-grade notes are due 2026
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market